- Home
- GTLB vs XOMAP Comparison
GTLB vs XOMAP Comparison
Compare GTLB & XOMAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTLB
- XOMAP
- Stock Information
- Founded
- GTLB 2011
- XOMAP N/A
- Country
- GTLB United States
- XOMAP United States
- Employees
- GTLB N/A
- XOMAP 13
- Industry
- GTLB EDP Services
- XOMAP Biotechnology: Pharmaceutical Preparations
- Sector
- GTLB Technology
- XOMAP Health Care
- Exchange
- GTLB Nasdaq
- XOMAP Nasdaq
- Market Cap
- GTLB 8.3B
- XOMAP N/A
- IPO Year
- GTLB 2021
- XOMAP N/A
- Fundamental
- Price
- GTLB $55.55
- XOMAP $26.51
- Analyst Decision
- GTLB Strong Buy
- XOMAP
- Analyst Count
- GTLB 27
- XOMAP 0
- Target Price
- GTLB $65.59
- XOMAP N/A
- AVG Volume (30 Days)
- GTLB 1.3M
- XOMAP N/A
- Earning Date
- GTLB 12-02-2024
- XOMAP N/A
- Dividend Yield
- GTLB N/A
- XOMAP N/A
- EPS Growth
- GTLB N/A
- XOMAP N/A
- EPS
- GTLB N/A
- XOMAP N/A
- Revenue
- GTLB $665,218,000.00
- XOMAP N/A
- Revenue This Year
- GTLB $30.87
- XOMAP N/A
- Revenue Next Year
- GTLB $24.25
- XOMAP N/A
- P/E Ratio
- GTLB N/A
- XOMAP N/A
- Revenue Growth
- GTLB 32.42
- XOMAP N/A
- 52 Week Low
- GTLB $40.19
- XOMAP N/A
- 52 Week High
- GTLB $78.53
- XOMAP N/A
- Technical
- Relative Strength Index (RSI)
- GTLB 57.83
- XOMAP 63.56
- Support Level
- GTLB $52.44
- XOMAP $26.24
- Resistance Level
- GTLB $57.90
- XOMAP $26.48
- Average True Range (ATR)
- GTLB 1.68
- XOMAP 0.13
- MACD
- GTLB 0.06
- XOMAP 0.03
- Stochastic Oscillator
- GTLB 66.91
- XOMAP 93.68
About GTLB GitLab Inc.
GitLab Inc operates on an all-remote model. GitLab, a complete DevSecOps platform delivered as a single application. It operates in two competitive landscapes: DevOps point solutions and DevOps platforms. In terms of point solutions that are stitched together, GitLab's offering is substantially different in that it is one platform, one codebase, one interface, and a unified data model that spans the entire DevSecOps lifecycle. DevOps platforms, the principal competitor is Microsoft Corporation following their acquisition of GitHub. GitLab is offered on both self-managed and software-as-a-service (SaaS) models. It is located in the United States, Europe, and Asia Pacific. It focused on accelerating innovation and broadening the distribution of its platform to companies across the world.
About XOMAP XOMA Corporation 8.625% Series A Cumulative Perpetual Preferred Stock
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.